Mo-BRUK (MBR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 2025 revenue grew 8.7–9% year-over-year, with 19% higher processed waste volume and 90% of sales from waste management services.
EBITDA margin in core business was 45%, with company-wide margin at 40.7–45%; El-Kajo facility contributed significantly.
Net profit for Q1 2025 was PLN 12.6 million, down 5.9% year-over-year, mainly due to higher depreciation and interest expenses.
Operating expenses rose 14.2% year-over-year, driven by higher depreciation, amortization, and external service costs.
The group remains a leader in industrial waste processing in Poland, with ongoing investments to expand capacity and efficiency.
Financial highlights
Q1 2025 revenues reached PLN 59.6 million, up from PLN 54.2 million in Q1 2024.
EBITDA for Q1 2025 was PLN 24.1–24.3 million, with a margin of 40.7–45%.
Net profit for Q1 2025 was PLN 12.6 million, down from PLN 13.4 million in Q1 2024.
Operating cash flow was PLN 15.1 million, with net cash outflow of PLN -7.1 million.
Total assets stood at PLN 478.1 million; equity at PLN 259.5 million; cash and equivalents at PLN 51.7 million.
Outlook and guidance
Management targets a 50% EBITDA margin in core business for 2025.
Further revenue growth and improved profitability are expected, supported by El-Kajo, new contracts, and market trends.
Anticipated interest rate cuts and principal repayments are expected to reduce interest expenses.
Market and regulatory trends are expected to drive demand for recycling and hazardous waste services.
No financial forecasts for 2025 were published.
Latest events from Mo-BRUK
- H1 2024 revenue up 7.2% to PLN 120.2m, but profit fell on higher costs and plant downtime.MBR
Q2 202423 Jan 2026 - Innovative recycling processes and legal wins drive growth in sustainable building materials.MBR
Investor presentation14 Jan 2026 - Revenue up 18% y/y, net profit down 10.6% as capacity and margins improve.MBR
Q3 202414 Jan 2026 - One-off write-down caused a net loss despite strong revenue and core business margins.MBR
Q3 20251 Dec 2025 - Record sales and EBITDA in 2024, with major investments boosting capacity and future growth.MBR
Q4 202414 Nov 2025 - Revenue and EBITDA rose in H1 2025, driven by medical waste and capacity expansion.MBR
Q2 202527 Aug 2025